Publications
“The global macroeconomic burden of Alzheimer’s disease and other dementias: estimates and projections for 152 countries or territories” (w/ S. Chen, Z. Cao, A.Nandi, N. Counts, L. Jiao, K. Prettner, M. Kuhn, B. Seligman, D. Vido, C. Wang and D. Bloom), The Lancet Global Health, Vol 12, No. 9, September 2024.
“The Economic Case for Scaling Up Health Research and Development: Lessons from the COVID-19 Pandemic”, (w/ R. Rappuoli and D. Bloom), Proceedings of the National Academy of Science (PNAS), Vol 121, No. 26, June 2024. [Replication Package]
“The Ten Trillion Dollar Disease,” (w/ David Bloom, Simiao Chen, Arindam Nandi, Zhong Cao, Nathaniel Counts, Maddalena Ferranna, Benjamin Seligman, and David Vigo), Scientific American, May 2024, Pages 24-31.
“Effective Health Aid: Evidence from Gavi’s Vaccine Program” (w/Gauri Kartini Shastry), AEJ:Economic Policy, Conditionally Accepted, January 2024
“Cost of care for Alzheimer’s disease and related dementias in the United States: 2016 to 2060” (w/ A. Nandi, N. Counts, J. Broker, S. Malik, S. Chen, R. Han, J. Klusty, B. Seligman, D. Vigo, D. Bloom), npj:Aging, Accepted, January 2024
“Lifecycle model-based evaluation of infant 4CMenB vaccination in the UK.” (w/ J.P Sevilla, D. Kantor, J. Regan, K.H. Meszaros, E.C. Beck, N. Begum and D. Bloom), The European Journal of Health Economics, pp.1-14. January 2024.
“Optimal Global Spending for Group A Streptococcus Vaccine Research and Development” (w/ M. Ferranna and D. Bloom), npj:Vaccines Vol 8, No. 62, April 2023.
“Global and regional projection of the economic burden of Alzheimer’s disease and related dementias from 2019 to 2050: a value of statistical life approach,” (w/ A. Nandi, N. Counts, S. Chen, B. Seligman, D. Vigo, D. Bloom) eClinicalMedicine, Vol 51, September 2022.
"The Trillion Dollar Vaccine Gap,” (w/ S. Pecetta, Simone, F. Scorza, M. Pizza, G. Dougan, R. Hatchett, S. Black, D. Bloom, and R. Rappuoli), Science Translational Medicine, Vol 14, No. 638 March 2022, pp.1-5.
“Dementia: Storm on the Horizon, (w/ Nathaniel Counts, Arindam Nandi, and Ben Seligman), Finance & Development, International Monetary Fund, December 2021, Pages 54-57. [World Economics Forum Blog Post]
“How New Models of Vaccine Development for COVID-19 Have Helped Address an Epic Public Health Crisis,” (w/ David Bloom, Dan Cadarette, Maddalena Ferranna, and Randy Hyer), Health Affairs, Vol. 40, No. 3, February 2021, pp.410-418.
"Same Firm, Two Volatilities:How Variance Risk is priced in Credit and Equity Markets" (joint w/ Arben Kita), Journal of Corporate Finance, 69(C), August 2021, Article #101885.
"Can Risk Models Extract Inflation Expectations from Financial Market Data? Evidence from the Inflation Protected Securities of Six Countries" (joint w/ Arben Kita), Journal of Money, Credit and Banking, Vol. 53, Issue 6, September 2021, pp. 1417-1448.
“An Ounce of Prevention,” (w/ David Bloom and Daniel Cadarette), Finance & Development, International Monetary Fund, September 2020, Pages 54-57.